ARTIVION, INC. Share-based Payment Arrangement, Expense, Tax Benefit
ARTIVION, INC. (AORT) reported Share-based Payment Arrangement, Expense, Tax Benefit of $600.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-18.
Financial Statements › Expense Statement › Income Tax
us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense · last filed 2026-02-18
- ARTIVION, INC. share-based payment arrangement, expense, tax benefit for fiscal 2025 was $600.00K, a 75.00% decline from fiscal 2024.
- ARTIVION, INC. share-based payment arrangement, expense, tax benefit for fiscal 2024 was $2.40M, a 25.00% decline from fiscal 2023.
- ARTIVION, INC. share-based payment arrangement, expense, tax benefit for fiscal 2023 was $3.20M, a 18.52% increase from fiscal 2022.
- ARTIVION, INC. share-based payment arrangement, expense, tax benefit for fiscal 2022 was $2.70M.
| Period end | Share-based Payment Arrangement, Expense, Tax Benefit 12 month |
|---|---|
| 2025-12-31 | $600.00K 10-K · filed 2026-02-18 |
| 2024-12-31 | $2.40M 10-K · filed 2026-02-18 |
| 2023-12-31 | $3.20M 10-K · filed 2026-02-18 |
| 2022-12-31 | $2.70M 10-K · filed 2025-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |